KNTE Market Cap History Table | ||||||||||||||||||||||||||
Also see: KNTE Shares Outstanding History and KNTE YTD Return |
KNTE Market Cap History Table | ||||||||||||||||||||||||||
Also see: KNTE Shares Outstanding History and KNTE YTD Return |
KNTE Market Cap History Chart | |||||||||||||||||||||||||||
-67.79% CAGR Mouse over chart for data details
|
KNTE Stock Price Chart |
About Kinnate Biopharma Inc |
Kinnate is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for genomically defined cancers. Co.'s focus is on three patient populations: those with cancers that harbor known oncogenic drivers with no available targeted therapies; those with genomically well-characterized tumors that have resistance to available treatments; and those whose tumors have acquired resistance over the course of therapy to available treatments. Co.'s product candidates are KIN002787, which is for the treatment of patients with lung cancer, melanoma and other solid tumors; and KIN-3248, which is targeting cancer-associated alterations in FGFR2. We show 12 historical shares outstanding datapoints in our KNTE shares outstanding history coverage, used to compute KNTE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing KNTE market cap history over the course of time is important for investors interested in comparing KNTE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of KNTE versus a peer is one thing; comparing KNTE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like KNTE can fluctuate over the course of history. With this page we aim to empower investors researching KNTE by allowing them to research the KNTE market cap history. |
KNTE Current Stock Quote |
Free KNTE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
KNTE Share Performance |
Market Cap Peers |
Kinnate Biopharma (KNTE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
KOD Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.